• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

LeonaBio, Inc. - Common Stock (NQ:LONA)

4.970 -0.700 (-12.35%)
Delayed Quote Updated: 4:00 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 49,807
Open 5.590
Bid (Size) 4.970 (100)
Ask (Size) 5.000 (300)
Prev. Close 5.670
Today's Range 4.690 - 5.671
52wk Range 2.210 - 14.21
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
LeonaBio to Participate in Cantor Global Healthcare Conference 2026
September 03, 2026
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update
August 14, 2026
From LeonaBio, Inc.
Via GlobeNewswire

Performance

52-Week Range 65.0% below 52-week high
4.970
2.2152W Low 14.2152W High
1 Week 13.6% below 1-week high
4.691W Low 5.751W High

LeonaBio, Inc. - Common Stock (LONA) traded between $2.21 and $14.21 over the past 52 weeks and last traded at $4.97, 65.0% below its 52-week high. Over the past week it ranged between $4.69 and $5.75.

Past 12 Months
-4.4%
-17.9%
-31.4%
-42.3%
-24.1%
-24.1%
1W -$0.23
1M -$1.08
3M -$2.27
6M -$3.65
YTD -$1.58
1Y -$1.58

LONA was -24.1% over the past year, -42.3% over six months, -24.1% year to date, -4.4% in the last week.

12 Months vs Market
LONA
-24.1%
DIA
+13.3%
SPY
+14.4%
QQQ
+16.3%
IWM
+13.7%

Over the past 12 months LONA returned -24.1% versus DIA (Dow) +13.3%, SPY (S&P 500) +14.4%, QQQ (Nasdaq 100) +16.3% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 0.27× 3-mo avg
Today 49,807 3-mo avg 187.4K
1W
45.1K
1M
445.8K
3M
187.4K
6M
113.0K
YTD
95.9K
1Y
95.9K

LONA most recently traded 49,807 shares against a 3-month average daily volume of 187.4K.

More News

Read More
News headline image
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer
August 12, 2026
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit
June 04, 2026
From LeonaBio, Inc.
Via GlobeNewswire
LeonaBio (NASDAQ:LONA) Beats Q1 Loss Estimates as Phase 3 Breast Cancer Trial Enrollment Expands ↗
May 07, 2026
Via Chartmill
News headline image
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
May 27, 2026
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update
May 07, 2026
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.
May 07, 2026
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer
April 23, 2026
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data
April 21, 2026
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update
March 26, 2026
From LeonaBio, Inc.
Via GlobeNewswire
News headline image
LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer
February 03, 2026
From LeonaBio, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is LeonaBio, Inc. - Common Stock publicly traded?
Yes, LeonaBio, Inc. - Common Stock is publicly traded.
What exchange does LeonaBio, Inc. - Common Stock trade on?
LeonaBio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for LeonaBio, Inc. - Common Stock?
The ticker symbol for LeonaBio, Inc. - Common Stock is LONA on the Nasdaq Stock Market
What is the current price of LeonaBio, Inc. - Common Stock?
The current price of LeonaBio, Inc. - Common Stock is 4.970
When was LeonaBio, Inc. - Common Stock last traded?
The last trade of LeonaBio, Inc. - Common Stock was at 10/22/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap